SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 905.91 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 382.53 |
| Book Value / Share | 3.20 |
| Price / Book | n/a |
| NCAV ($M) | 318.07 |
| NCAV / Share | 2.66 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.14 |
| Return on Assets (ROA) | -0.13 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.98 |
| Current Ratio | 3.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 512.78 |
| Assets | 577.23 |
| Liabilities | 194.71 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Rtw Investments, Lp | 9.70 | ||
| 13G | T. Rowe Price Investment Management, Inc. | 7.20 | ||
| 13G/A | Wellington Management Group Llp | 9.40 | 52.39 | |
| 13D/A | Perceptive Advisors Llc | 7.90 | 15.90 | |
| 13G/A | Arya Sciences Holdings | 0.00 | -100.00 | |
| 13G/A | Baker Bros. Advisors Lp | 6.90 | 12.57 | |
| 13G/A | Athos Kg | 5.80 | -0.01 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 28,244 | 564,401 | 5.00 | |
| 60,360 | 518,921 | 11.63 | |
| 117,940 | 728,768 | 16.18 | |
| 132,845 | 642,152 | 20.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMMX – Immix Biopharma, Inc. | IMNM – Immunome, Inc. |
| IMNN – Imunon, Inc. | INDP – Indaptus Therapeutics, Inc. |
| INKT – MiNK Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io